Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 50268-028

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 50268-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Structure001)

Chemical structure diagram of Acamprosate Calcium showing two molecules with their acetate and sulfonate groups, including a calcium ion (Ca2+). The structure illustrates the arrangement of atoms and functional groups typical for this active ingredient.*

FDA Label Image

1 (028 13)

Label for Acamprosate Calcium DR 333 mg delayed-release tablets. The label shows 30 tablets (6 x 5) as unit dose packaging. It includes dosage information, storage instructions, manufacturer AvPAK details, and a barcode. The label emphasizes prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.